The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

被引：2
|
作者：
Dobler, Claudia C. [1 ]
机构：
[1] Mayo Clin, Evidence Based Practice Ctr, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA
来源：
BREATHE | 2018年 / 14卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1183/20734735.026418
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：333 / 335
页数：3
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYA') VS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE
    Balmaceda, C.
    Abbott, T.
    Espinoza, M. A.
    VALUE IN HEALTH, 2020, 23 : S354 - S354
  • [42] Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review
    Rana, Rezwanul Hasan
    Alam, Khorshed
    Keramat, Syed Afroz
    Gow, Jeff
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (10) : 1067 - 1084
  • [43] Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice
    Lassan, S.
    Keszegh, J.
    Lassanova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (01): : 27 - 36
  • [44] ECONOMIC ANALYSIS OF NEW SINGLE-INHALER TRIPLE THERAPIES IN PATIENTS WITH COPD IN THE UK
    Cai, R.
    Martin, A.
    Ge, Y.
    Risebrough, N.
    Sharma, R.
    Haeussler, K.
    Compton, C.
    Halpin, D.
    Ismaila, A. S.
    VALUE IN HEALTH, 2022, 25 (12) : S183 - S184
  • [45] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2021, 26 : 119 - 119
  • [46] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, A.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2020, 25 : 145 - 145
  • [47] Therapeutic Response to Single-Inhaler Triple Therapies in Moderate-to-Severe COPD
    Ohtsuka, Kengo
    Harada, Naoko
    Horiuchi, Atsuo
    Umemoto, Shintaro
    Kurabatashi, Ryo
    Yui, Akie
    Yamamura, Hiroyuki
    Shinka, Yoko
    Miyao, Naoki
    RESPIRATORY CARE, 2023, 68 (03) : 330 - 337
  • [48] THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Vallejo-Aparicio, L. A.
    Paly, V. F.
    Schroeder, M.
    Martin, A.
    Risebrough, N.
    Abreu, C.
    Biswas, C.
    Izquierdo Alonso, J. L.
    Riesco Miranda, J. A.
    Soler Cataluna, J. J.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S878 - S878
  • [49] Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD
    Miravitlles, Marc
    Marin, Alicia
    Huerta, Alicia
    Carcedo, David
    Villacampa, Alba
    Puig-Junoy, Jaume
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1643 - 1654
  • [50] Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (vol 37, pg 3775, 2020)
    Tabberer, Maggie
    Jones, C. Elaine
    Kilbride, Sally
    Halpin, David M. G.
    Lomas, David A.
    Pascoe, Steven
    Singh, Dave
    Wise, Robert A.
    Criner, Gerard J.
    Lange, Peter
    Dransfield, Mark T.
    Han, MeiLan K.
    Martinez, Fernando J.
    Kaisermann, Morrys C.
    Lipson, David A.
    ADVANCES IN THERAPY, 2022, 39 (03) : 1446 - 1446
12345